Skip to main content

MS linked to about 9% of eye nerve inflammation in Japan

By MS Buddy ·

Summarized from Japanese journal of ophthalmology, Nov 2026 · PubMed · DOI. AI-generated summary. Not medical advice.

Observational study · 112 Japanese people with a first episode of eye nerve inflammation

Research by Noriko Himori, Toru Nakazawa and 4 colleagues at Tohoku University Graduate School of Medicine in Japan.

How often is MS found after a first episode of eye nerve inflammation in Japan?

Key Takeaway

MS accounted for about 9% of first episodes of eye nerve inflammation among patients studied at one Japanese hospital.

Cut-paper eye and ribbon-like nerve with a small overlapping terracotta shape on a warm off-white background.
Credibility
Interest
Share:1 min read

What They Found

MOG antibody disease (an immune condition that can inflame eye nerves) accounted for about 37% of cases. Neuromyelitis optica (another immune condition that can inflame eye nerves) accounted for about 21%. About 33% had no identified underlying cause, while about 9% had MS. Among patients followed for more than 12 months, about 18% had another attack. Rates of remaining free from another attack did not clearly differ between the disease groups.

Who Should Care and Why

The study included Japanese patients with a first episode of optic neuritis (inflammation of the nerve connecting the eye and brain). Researchers reviewed records from Tohoku University Hospital. MS was one of several underlying diseases studied, rather than the main focus. Patients had blood tests before treatment to look for immune proteins linked to specific diseases. Eye nerve inflammation linked to these immune proteins occurred across a wide age range.

Important Considerations

This study reviewed past medical records from 112 patients at one hospital, rather than randomly assigning treatments. Only 90 patients had follow-up lasting more than 12 months. The abstract does not establish whether early diagnosis or coordinated treatment improved long-term outcomes.

AI-generated summary — for informational purposes only, not medical advice

Read the original abstract

Published in Japanese journal of ophthalmology by et al.. Reproduced from the PubMed record.

To investigate the distribution of underlying diseases in optic neuritis and related clinical characteristics, treatment strategies, and relapse patterns in Japanese patients using strict radiological diagnostic criteria and pretreatment antibody testing. Retrospective cohort study METHODS: We retrospectively reviewed the charts of 112 patients with first-onset optic neuritis who visited Tohoku University Hospital between March 2016 and November 2025. Diagnoses of optic neuritis were based on visual dysfunction and contrast-enhanced orbital magnetic resonance imaging. Serum anti-myelin oligodendrocyte glycoprotein (MOG) antibodies and anti-aquaporin-4 antibodies were measured using live-cell-based assays before initiation of acute-phase treatment. Patients were classified into groups according to the following underlying diseases: MOG-associated disease (MOGAD), neuromyelitis optica spectrum disorder (NMOSD), multiple sclerosis (MS), and idiopathic optic neuritis. Clinical characteristics, treatment strategies, relapse rates, and cumulative relapse rates were analyzed retrospectively. The distribution of underlying diseases was 36.6% MOGAD, 33.0% idiopathic, 21.4% NMOSD, and 8.9% MS. MOGAD patients were characterized by a younger onset, bilateral involvement, and more frequent optic disc swelling, whereas NMOSD patients were predominantly women, older at onset, and had unilateral involvement. Among the 90 patients followed for more than 12 months, the overall relapse rate was 17.8%, with the highest relapse rate observed for NMOSD (25.0%). Kaplan-Meier analysis demonstrated gradually decreasing cumulative relapse-free rates, particularly in NMOSD and idiopathic optic neuritis. The 36-month cumulative relapse-free rates were 81.6% in MOGAD, 87.5% in MS, 72.9% in NMOSD, and 61.3% in idiopathic optic neuritis. No significant difference in relapse-free rates was observed among underlying diseases (log-rank test, p = 0.84). MOGAD and NMOSD accounted for a relatively large proportion of optic neuritis cases in study population. Antibody-associated optic neuritis was observed across a wide age range, suggesting the importance of antibody testing regardless of age. Early diagnosis and multidisciplinary therapeutic intervention may contribute to improved long-term outcomes.

Categories

The app

Check out the MS Buddy app

It’s free, with no ads. Built by people living with MS.

Download on the App StoreGet it on Google Play

Related MS research

Two soft, overlapping layers sweep across muted dots, with a small cluster clearer through one layer.
Spinal fluid test flagged MS cases another test missed

11/20/2026

In a study of 140 people, a spinal fluid test better separated MS from other nervous system conditio

Read More
A crisp scan slice lines up with parallel strokes, while a fainter slice tilts across them.
Lining up MS brain scans gave stronger scan readings

11/20/2026

In people with MS, brain scan readings were stronger when images lined up with the scanner’s magneti

Read More
Overlapping blue-gray and lavender layers with small patches, aligned contours and a short, gently curving path.
AI scan tool improved MS checks and saved reading time

11/20/2026

A study of 59 people with relapsing-remitting MS found a computer tool helped doctors read brain sca

Read More
Two matching brain lesion shapes, with a central vein faint on the left and more clearly visible on the right.
Adjusted MRI spots more veins inside MS brain lesions

11/18/2026

An adjusted MRI scan found more veins within MS brain lesions in 17 people with MS. It improved scan

Read More
Muted branching paths cross translucent layers, revealing a small irregular pattern at their overlap.
Brain scans after a car crash revealed MS in a teen

1/1/2026

After a car crash, brain and spine scans revealed signs of MS in an 18-year-old male. Further tests

Read More
Brain outline with connecting fibers between its halves, some subtly lighter than others.
MS brain scans cannot confirm nerve signal failure

11/14/2026

An opinion paper explains why MS brain scans can show tissue loss without proving nerve signal failu

Read More

Not all studies carry the same weight: sample size, study design and whether results were replicated all matter. The credibility score above reflects the journal, and the original paper is linked under More Details. Read how MS Buddy selects and scores research, and talk to your MS care team before acting on any study.